Study Results from University of Texas MD Anderson Cancer Center Update Understanding of Acute Lymphoblastic Leukemia (Ponatinib Vs Imatinib In Frontline Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia)

Source :: Health & Medicine Week. June 21, 2024, 7749
Publication Year :: 2024
Abstract: 2024 JUN 21 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Research findings on Oncology - Acute Lymphoblastic Leukemia are discussed in a new [...]

Subjects :: Takeda Pharmaceutical Company Ltd.
University of Texas. M.D. Anderson Cancer Center
Genetic aspects
Ponatinib
Genetic research -- Genetic aspects
Cancer genetics -- Genetic aspects
Cancer research -- Genetic aspects
Tyrosine -- Genetic aspects
Pharmaceutical industry
Acute lymphocytic leukemia -- Genetic aspects
Oncology, Experimental -- Genetic aspects
Cancer -- Genetic aspects -- Research

Tools